Vivaldi Biosciences Inc., a clinical-stage biotechnology company developing live attenuated influenza vaccines (LAIVs) against seasonal and pandemic influenza, today announced that it has signed a Cooperative Research and Development ...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the National Institute of Allergy and Infectious Diseases (NIAID) has exercised an option to conduct the investigational new drug (IND) enabling program and to submit an IND. ...
Tags: BioCryst, NIAID, investigational new drug, BCX4430, Marburg virus disease
Pfenex has received a subcontract from Leidos Holdings (LDOS) to support the development of an anthrax vaccine containing its recombinant protective antigen (rPA) and a novel, immune-enhancing adjuvant. The initial contract was awarded by ...
Tags: Pfenex, Anthrax Vaccine
Scientists from Northwestern University have developed a new intravaginal ring that could help prevent women from immunodeficiency virus. The ring is easily inserted and stays in place for 30 days,delivering a measured amount of the ...
Tags: Immunodeficiency Virus, Medicine
Biopharmaceutical company Soligenix has secured a contract worth $6.4m from the US Department of Health and Human Service's National Institutes of Health (NIH), for the advanced preclinical development of OrbeShield (oral beclomethasone ...
Corgenix Medical has received the notification of CE Mark for its Relasv antigen rapid test for Lassa fever diagnosis. Relasv is the diagnostic test developed by Corgenix and members of the Viral Hemorrhagic Fever Consortium (VHFC), a ...
Tags: Corgenix Medical, Rapid Test
VaxInnate, a US-based biotechnology firm, has received a grant from the National Institute of Allergy and Infectious Diseases (NIAID) to fund the development of a recombinant vaccine for the prevention of dengue. The grant will provide ...
Researchers at the National Institutes of Health (NIH) have begun enrolling volunteers for clinical trials to find effective treatments for influenza. One of the studies will assess if treatment with the influenza drug oseltamivir reduces ...
SRI International has received a new grant from the National Institute of Allergy and Infectious Diseases (NIAID) to develop a topical microbicide gel for drug delivery. The topical microbicide gel, which will be based on a patented ...
Collaborative Drug Discovery (CDD) and SRI International have won a second grant from the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, for the joint development of an ...
Tags: Collaborative Drug Discovery, CDD, tuberculosis, TB
The University of Washington (UW), University of Texas Medical Branch (UTMB) at Galveston, US, and Kineta have been granted a $8.1m biodefense award by the National Institute of Allergy and Infectious Diseases (NIAID). The funding aims to ...
Tags: the National Institute of Allergy and Infectious Diseases
A 5 year $5.4m grant has been awarded to Profectus BioSciences and the Galveston National Laboratory (GNL) at the University of Texas Medical Branch at Galveston to support the development of a Vesicular Stomatitis virus-vectored vaccine ...
Tags: Trivalent Vaccine, rVSV-vectored filovirus, Ebola and Marburg Viruses
The National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes of Health has awarded Phase I small business innovation research grant of $600,000 to Antigen Discovery to develop a microfluidic point of care ...
Tags: POC diagnostic device, diagnostic device, serodiagnostic antigens